Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
11
×
life sciences
national blog main
san diego blog main
san diego top stories
biotech
boston blog main
boston top stories
national top stories
clinical trials
new york blog main
new york top stories
san francisco blog main
san francisco top stories
archive
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
medical
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
national
boston
bristol-myers squibb
cancer
deals
drugs
eli lilly
immunotherapy
investing
loxo oncology
What
time
11
×
fda
approved
drug
administration
approval
approves
called
days
food
friday
health
management
medication
medicine
new
patients
weeks
world
acquire
add
adding
adults
advising
agency
ago
aimmune
airport
allergy
alliance
alnylam
announcement
annual
apocalypse
appetite
approve
atrial
awaits
awarded
bec
Language
unset
Current search:
time
×
fda
×
@slashgear.com
2 years ago
FDA approves powerful appetite suppressant for obese adults
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@slashgear.com
3 years ago
Popular thyroid drugs recalled because they’re weaker than expected
@xconomy.com
3 years ago
Neurocrine Gets FDA Nod for Once-Daily “Add-On” Parkinson’s Pill
@slashgear.com
4 years ago
FDA warns dangerous chlorine dioxide products won’t cure COVID-19
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@slashgear.com
4 years ago
FDA approves first US Ebola vaccine: What you should know
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision
@xconomy.com
5 years ago
Boston Scientific Continues M&A Streak with $202M Deal for Cryterion